Bioengineering of differentiated hepatocytes with human factor IX-expressing plasmids in vitro

References

• Mannucci PM, Tuddenham EG. The hemophilias from royal genes to gene therapy. N Engl J Med 2001; 344:1773-9; PMID:11396445; http://dx.doi.org/10.1056/NEJM200106073442307
   PubMed Web of Science ®Google Scholar
• Bajaj SP, Sabharwal AK, Gorka J, Birktoft JJ. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain. Proc Natl Acad Sci U S A 1992; 89:152-6; PMID:1729682; http://dx.doi.org/10.1073/pnas.89.1.152
   PubMed Web of Science ®Google Scholar
• Hedner U, Ginsburg D, Lusher JM, High KA. Congenital hemorrhagic disorders: New insights into the pathophysiology and treatment of hemophilia. Hematology Am Soc Hematol Educ Program 2000; 241-65; PMID:11701545; http://dx.doi.org/10.1182/asheducation-2000.1.241
   PubMedGoogle Scholar
• Ragni MV. Hemophilia gene transfer: comparison with conventional protein replacement therapy. Semin Thromb Hemost 2004; 30:239-47; PMID:15118935; http://dx.doi.org/10.1055/s-2004-825637
   PubMed Web of Science ®Google Scholar
• Roth DA, Kessler CM, Pasi KJ, Rup B, Courter SG, Tubridy KL. Recombinant Factor IX Study Group. Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates. Blood 2001; 98:3600-06; PMID:11739163; http://dx.doi.org/10.1182
   PubMed Web of Science ®Google Scholar
• Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 1993; 262:117-9; PMID:8211118; http://dx.doi.org/10.1226/science.8211118
   PubMed Web of Science ®Google Scholar
• High KA. Clinical gene transfer studies for hemophilia B. Semin Thromb Hemost 2004; 30:257-67; PMID:15118937; http://dx.doi.org/10.1055/s-2004-825639
   PubMed Web of Science ®Google Scholar
• Armentano D, Thompson AR, Darlington G, Woo SL. Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci U S A 1990; 87:6141-5; PMID:2385589; http://dx.doi.org/10.1073/pnas.87.16.6141
   PubMed Web of Science ®Google Scholar
• Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci U S A 1992; 89:10892-5; PMID:1332058; http://dx.doi.org/10.1073/pnas.89.8.3357
   PubMed Web of Science ®Google Scholar
• Page SM, Brownlee GG. An ex vivo keratinocyte model for gene therapy of hemophilia B. J Invest Dermatol 1997; 109:139-45; PMID:9242498; http://dx.doi.org/10.1111/1523-1747.ep12319194
   PubMed Web of Science ®Google Scholar
• Hosseini SJ, Zomorodipour A, Jalal R, Sabouni F, Ataei F. A study of the expression of functional human coagulation factor IX in keratinocytes using a nonviral vector regulated by K14 promoter. Appl Biochem Biotechnol 2010; 162:1599-611; PMID:20397061; http://dx.doi.org/10.1007/s12010-010-8941-0
   PubMed Web of Science ®Google Scholar
• Yao SN, Wilson JM, Nabel EG, Kurachi S, Hachiya HL, Kurachi K. Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc Natl Acad Sci USA 1991; 88:8101-5; PMID:1896457; http://dx.doi.org/10.1073/pnas.87.12.4421
   PubMed Web of Science ®Google Scholar
• Krebsbach PH, Zhang K, Malik AK, Kurachi K. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model. J Gene Med 2003; 5:11-7; PMID:12516047; http://dx.doi.org/10.1002/jgm.292
   PubMed Web of Science ®Google Scholar
• Chang AH, Stephan MT, Sadelain M. Stem cell-derived erythroid cells mediate long-term systemic protein delivery. Nat Biotechnol 2006; 24:1017-21; PMID:16845377; http://dx.doi.org/10.1038/nbt1227
   PubMed Web of Science ®Google Scholar
• Sam MR, Azadbakhsh AS, Farokhi F, Rezazadeh K, Sam S, Zomorodipour A, Haddad-Mashadrizeh A, Delirezh N, Mokarizadeh A. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids. Biologicals 2016; 44:170-7; PMID:26928674; http://dx.doi.org/10.1016/j.biologicals.2016.01.002
   PubMed Web of Science ®Google Scholar
• Dobrzynski E, Herzog RW. Tolerance induction by viral in vivo gene transfer. Clin Med Res 2005; 3:234-40; PMID:16303889; http://dx.doi.org/10.3121/cmr.3.4.234
   PubMedGoogle Scholar
• Bigger BW, Siapati EK, Mistry A, Waddington SN, Nivsarkar MS, Jacobs L, Perrett R, Holder MV, Ridler C, Kemball-Cook G, et al. Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX. Gene Ther 2006; 13:117-26; PMID:16163377; http://dx.doi.org/10.1038/sj.gt.3302638
   PubMed Web of Science ®Google Scholar
• Miao CH, Thompson AR, Loeb K, Ye X. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol Ther 2001; 3:947-57; PMID:11407909; http://dx.doi.org/10.1006/mthe.2001.0333
   PubMed Web of Science ®Google Scholar
• Okkema PG, Harrison SW, Plunger V, Aryana A, Fire A. Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans. Genetics 1993; 135:385-404; PMID:8244003; http://dx.doi.org/10.1371/journal.pgen.1002991
   PubMed Web of Science ®Google Scholar
• Kim VN, Kataoka N, Dreyfuss G. Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex. Science 2001; 293:1832-6; PMID:11546873; http://dx.doi.org/10.1126/science.1062829
   PubMed Web of Science ®Google Scholar
• Le Hir H, Gatfield D, Izaurralde E, Moore MJ. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J 2001; 20:4987-97; PMID:11532962; http://dx.doi.org/10.1093/emboj/20.17.4987
   PubMed Web of Science ®Google Scholar
• Dostie J, Dreyfuss G. Translation is required to remove Y14 from mRNAs in the cytoplasm. Curr Biol 2002; 12:1060-7; PMID:12121612; http://dx.doi.org/10.1016/S0960-9822(02)00902-8
   PubMed Web of Science ®Google Scholar
• Wiegand HL, Lu S, Cullen BR. Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. ProcNatlAcadSci U S A 2003; 100:11327-32; PMID:12972633; http://dx.doi.org/10.1073/pnas.1934877100
   PubMed Web of Science ®Google Scholar
• Kurachi S, Hitomi Y, Furukawa M, Kurachi K. Role of intron I in expression of the human factor IX gene. J BiolChem 1995; 270:5276-81; PMID:7890639; http://dx.doi.org/10.1074/jbc.270.10.5276
   PubMed Web of Science ®Google Scholar
• Haddad-Mashadrizeh A, Zomorodipour A, Izadpanah M, Sam MR, Ataei F, Sabouni F, Hosseini SJ. A systematic study of the function of the human beta-globin introns on the expression of the human coagulation factor IX in cultured Chinese hamster ovary cells. J Gene Med 2009; 11:941-50; PMID:19565465; http://dx.doi.org/10.1002/jgm.1367
   PubMed Web of Science ®Google Scholar
• Harding TC, Koprivnikar KE, Tu GH, Zayek N, Lew S, Subramanian A, Sivakumaran A, Frey D, Ho K, VanRoey MJ, et al. Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B. Gene Ther 2004; 11:204-13; PMID:14712305; http://dx.doi.org/10.1038/sj.gt.3302142
   PubMed Web of Science ®Google Scholar
• Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL. Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci U S A 1991; 88:478-82; PMID:1988947; http://dx.doi.org/10.1073/pnas.88.2.478
   PubMed Web of Science ®Google Scholar
• Lacy-Hulbert A, Thomas R, Li XP, Lilley CE, Coffin RS, Roes J. Interruption of coding sequences by heterologous introns can enhance the functional expression of recombinant genes. Gene Ther 2001; 8:649-53; PMID:11320412; http://dx.doi.org/10.1038/sj.gt.3301440
   PubMed Web of Science ®Google Scholar
• Fair DS, Bahnak BR. Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III. Blood 1984; 64:194-204; PMID:6329378
   PubMed Web of Science ®Google Scholar
• Vatandoost J, Zomorodipour A, Sadeghizadeh M, Aliyari R, Bos MH, Ataei F. Expression of biologically active human clotting factor IX in Drosophila S2 cells: γ-carboxylation of a human vitamin K-dependent protein by the insect enzyme. Biotechnol Prog 2012; 28:45-51; PMID:22012919; http://dx.doi.org/10.1002/btpr.723
   PubMed Web of Science ®Google Scholar
• Kaufman RJ, Wasley LC, Furie BC, Furie B, Shoemaker CB. Expression, purification and characterization of recombinant g-carboxylated factor IX synthesized in Chinese hamster ovary cells. J BiolChem 1996; 261:9622-8; PMID:3733688; http://dx.doi.org/10.1111/j.1365-2516.2008.01828.x
   PubMed Web of Science ®Google Scholar